Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada.
Ethan Miller | Getty Images
Abbott Laboratories announced on Monday it received approval from the U.S. Food and Drug Administration for two new continuous glucose monitoring systems, including one for people who don’t have diabetes. Both will be available over-the-counter without a prescription.
A continuous glucose monitor, or a CGM, is a small sensor that pokes through the skin and tracks a person’s glucose levels in real time. It wirelessly transmits this data to a smartphone. CGMs are primarily used by patients with diabetes since the tech can help alert users, their families, and their doctors to emergencies.
The market opportunity could be significant for Abbott, whose existing CGMs are already used by around 6 million patients across 60 countries, Abbot said. Around 38.4 million people are living with diabetes in the U.S. alone, Abbott said, and offering a consumer-facing CGM brings the technology to an entirely new population.
One of Abbott’s new systems, Libre Rio, is for patients with Type 2 diabetes who do not take insulin. Its second system, Lingo, is for consumers trying to improve their health and wellness, according to the company.
Abbott said Lingo users will wear a biosensor on their upper arm for 14 days at a time, and they can track their glucose data within a coaching app on their phone. Participants get access to customized coaching based on their data that can help them “retrain their metabolism and improve their overall wellbeing,” the company said.
Several companies like Signos use CGMs to help people lose weight and improve their metabolic health. Oftentimes, users need a valid CGM prescription to participate in these programs, so Abbott’s new over-the-counter offering could be more accessible for some consumers.
Libre Rio is Abbott’s first over-the-counter offering for people with diabetes in the U.S., though other CGMs within its portfolio have been available without a prescription in other countries over the last decade. Libre Rio is designed for Type 2 patients who usually manage their diabetes with lifestyle modifications, the company said.
Abbott competitor Dexcom, which also sells CGM systems, received FDA approval for its first-ever over-the-counter CGM in March.
Microsoft CEO Satya Nadella speaks at Axel Springer Neubau in Berlin on Oct. 17, 2023
Ben Kriemann | Getty Images
Microsoft said last week that it plans to stop providing discounts on enterprise purchases of its Microsoft 365 productivity software subscriptions and other cloud applications.
Since the announcement, analysts have published estimates on how much more customers will end up paying. But for investors trying to figure out what it all means to Microsoft’s financials, analysts at UBS said the change is already factored into guidance.
“In our view, it is safe to assume that the impact of the pricing change” was included in Microsoft’s forecast, the analysts wrote in a report late Tuesday. They have a buy rating on the stock.
Microsoft’s disclosure, on Aug. 12, came two weeks after the software company, it its fiscal fourth-quarter earnings report, issued a forecast that included double-digit year-over-year revenue growth for the new fiscal year. The shares rose 4% after the report.
Microsoft said in its blog post announcing the pricing change that, “This update builds on the consistent pricing model already in place for services like Azure and reflects our ongoing commitment to greater transparency and alignment across all purchasing channels.”
The change applies to companies with enough employees to get them into price levels known as A, B, C and D. It goes into effect when organizations sign up for new services or renew existing agreements, beginning on Nov. 1.
“This action allows us to deliver more consistent and transparent pricing and better enable clear, informed decision making for customers and partners,” a Microsoft spokesperson told CNBC in an email.
Jay Cuthrell, product chief at Microsoft partner NexusTek, said customers will see price hikes of 6% to 12%. Partners are estimating an impact as low as as 3% and as high as 14%, UBS analysts wrote.
Microsoft 365 commercial seat growth, a measurement of the number of licenses that clients buy for their workers, has been under 10% since 2023. Microsoft is aiming to generate more revenue per seat by selling Copilot add-ons and moving some users to more expensive plans.
Expanding that part of the business is crucial. Most of Microsoft’s $128.5 billion in fiscal 2025 operating profit came from the Productivity and Business Processes unit, and about 73% of the revenue in that segment was from Microsoft 365 commercial products and cloud services.
Some customers could agree to pay Microsoft more to keep using the applications rather than moving to alternative services, said Adam Mansfield, practice lead at advisory firm UpperEdge. They may also lower their commitments to Microsoft in other areas, such as Azure cloud infrastructure, Mansfield said.
One way companies could potentially pay lower prices with the disappearance of discounts is by buying through cloud resellers instead of going direct, said Nathan Taylor, a senior vice president at Sourcepass, an IT service provider that caters to small businesses.
Sourcepass hasn’t gotten many leads as a result of Microsoft’s change yet, Taylor said.
“It takes a while for that information to disseminate to the industry at large,” he said.
Microsoft shares are up 20% this year, while the Nasdaq has gained about 10%.
Alibaba’s global headquarters in Hangzhou, Zhejiang Province, China, on May 9, 2024.
Nurphoto | Nurphoto | Getty Images
Alibaba-backed Banma, a provider of technology for smart cars, is planning to list shares on the Hong Kong Stock Exchange, according to a filing.
In a filing dated Aug. 21, Alibaba said it currently owns about 45% of Banma and will continue to control over 30% of the company’s stock after the listing. Banma said in a filing that the announcement does not guarantee a listing will take place.
Banma, founded in 2015 and based in Shanghai, is “principally engaged in the development of smart cockpit solutions,” Alibaba’s filing says. In March, Alibaba announced that it was deepening its partnership with BMW in China, building an artificial intelligence engine for cars with a solution built by Banma, “Alibaba’s intelligent cockpit solution provider.”
In addition to Alibaba, Banma is backed by investors including China’s SAIC Motor, SDIC Investment Management and Yunfeng Capital, a Chinese investment firm started by Alibaba co-founder Jack Ma.
Alibaba in the past referred to Banma as a joint venture “between us and SAIC Motor.”
Private renewable energy projects are still moving forward despite a pullback in government support, and new technology is making that construction more efficient.
Solar farms, for example, take meticulous planning and surveying, involve long hours and require significant labor. Now, robots are taking on the job.
CivDot is a four-wheeled robot that can mark up to 3,000 layout points per day and is accurate within 8 millimeters. The machine can ride over rugged terrain and work through rough weather.
It is the brainchild of California-based Civ Robotics.
“Our secret sauce and our core technology is actually in the navigation and the geospatial — being able to literally mark coordinates within less than a quarter inch, which is very, very difficult in an uneven terrain, outdoor surfaces, and out in the desert,” said Tom Yeshurun, CEO of Civ Robotics.
The data for manual surveying is uploaded into the Civ software, then the operator chooses the area they want to mark and presses go. The robot does the rest, saving both time and money.
Read more CNBC tech news
“The manual surveying equipment, if you use that in the field and you have three crews, they will need three land surveying handheld receivers. That alone is already equal to how much we lease our machines in the field, and all the labor savings is just another benefit,” Yeshurun said.
Civ Robotics has more than 100 of these robots in the field that are primarily being used by renewable energy companies, but they are also used in oil and gas. It is currently working with Bechtel Corporation on several solar projects.
“These were usually pretty highly paid field engineers that we would send out there, and they might be able to do 250 or 350 pile marks a day. With the CivDot robot, we’re able to do about 1250 a day,” said Kelley Brown, vice president at Bechtel.
Brown said the company has used the robot in thick and muddy terrain in Texas and out in the deserts of Nevada.
“And so you have to think about things like the tires, or you may have to think about clearance. Are you trying to get over existing brush and such, across the solar field? So that’s one thing that we contemplate. I think the other is, you know, this runs on batteries, so you’ve got to contemplate battery swaps,” she added.
Civ Robotics is backed by Alleycorp, FF Venture Capital, Bobcat Company, Newfund Capital, Trimble Ventures, and Converge. Total VC funding to date is $12.5 million.
There are other robotics solutions for markings, but the competition is mostly doing work on highways and soccer fields. Yeshurun said those rivals can’t handle the terrains that the solar industry faces as it expands into new territories.
CNBC producer Lisa Rizzolo contributed to this piece.